Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Emaus Apotek AB
AB
Active
Org 5567918940
Vegaplan 1, 734 30
Hallstahammar
Retail sale of pharmaceutical products
· NACE 4773
Est. 2009
1 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Emaus Apotek AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
5M
9M
14M
18M
15M
2021
14M
2022
15M
2023
16M
2024
15M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
15 460
14 498
15 156
15 929
14 705
Staff expenses
—
—
—
—
−1 379
EBITDA
1 354
916
733
584
704
Depreciation & amort.
−0
−0
−0
−0
—
EBIT
1 354
916
733
584
704
Net financials
−1
−1
—
3
12
Profit before tax
1 354
916
732
587
716
Tax
−292
−191
−152
−122
−151
Net profit
1 062
725
580
465
565
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
3 798
3 918
4 343
4 187
4 200
Equity
2 156
2 443
2 613
2 638
2 734
Long-term debt
0
0
0
0
—
Short-term debt
1 642
1 475
1 730
1 549
1 465
Total debt
1 642
1 475
1 730
1 549
1 465
Financial ratios
5-year trend
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
2021
2025
Equity ratio
65.1%
This company
38.2%
Market median
+70% vs market
2021
2025
Return on equity
20.6%
This company
18.4%
Market median
+12% vs market
2021
2025
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
2021
2025
Asset turnover
3.50×
This company
1.12×
Market median
+212% vs market
2021
2025
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Emaus Apotek AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network